Cardiovascular outcomes trials for glucose-lowering therapies : what do the results mean for practice?
Abstract
DigestDEBATE: In this section, a panel of multidisciplinary team members give their opinions on a recently published paper. In this issue, we discuss the outcome of the cardiovascular safety trial of empagliflozin, and what the results mean for clinical practice in the UK.
Citations
Altmetric:
Date
2015-12-15
Type
Article
Subject
Diabetes
Collections
Citation
Newland-Jones P, Patel V. Cardiovascular outcomes trials for glucose-lowering therapies: What do the results mean for practice? Diabetes Digest. 2015 December;14(4):191-192.
Journal / Source Title
Diabetes Digest
DOI
PMID
Publisher
SB Communications Group
Publisher’s URL
https://diabetesonthenet.com/diabetes-digest/cardiovascular-outcomes-trials-for-glucose-lowering-therapies-what-do-the-results-mean-for-practice/